NMN for Women Over 60: Is It Too Late to Start?

Women Over 60 Guide · Updated June 2026

The most consistent question from women over 60 researching NMN: have I left it too late? It is a reasonable concern — longevity supplement marketing often targets people in their 40s and 50s, and the emphasis on "prevention" can imply the window for cellular intervention has closed by your 60s.

The clinical evidence says otherwise. NAD+ depletion continues and accelerates through your 60s and 70s — reaching less than 25% of youthful levels by 80. And the most directly applicable human NMN trial — Yoshino et al., Cell Metabolism, 2021 — was conducted specifically in postmenopausal women. Not a proxy population. The exact demographic asking this question.

What Happens to NAD+ in Your 60s

NAD+ does not plateau — it continues declining. The trajectory: roughly 50% reduction by age 60, approaching 75% reduction by age 80. This means the NAD+ depletion a 65-year-old woman experiences is approximately double what a 45-year-old experiences. The cellular consequences compound accordingly.

Post-menopause adds a specific layer: the loss of oestrogen's mitochondria-supporting, neuroprotective, and metabolic regulatory roles removes a significant cellular health buffer at exactly the point when NAD+ depletion is becoming most severe. The compound effect — deep NAD+ depletion + post-menopausal oestrogen absence — is the cellular reality most 60+ women are managing.

This is not an argument that it is "too late" — it is an argument that it is more relevant to start than to wait further.

The Clinical Trials Most Relevant to Women Over 60

Yoshino et al. (Cell Metabolism, 2021): Postmenopausal women with pre-diabetes received 250mg NMN daily for 10 weeks. Result: significant improvement in skeletal muscle insulin sensitivity — the metabolic function most commonly impaired in post-menopausal women. This is the most directly applicable human NMN trial for this demographic.

Igarashi et al. (NPJ Aging, 2022): Adults with mean age 65 received 250mg NMN daily for 12 weeks. Results: significant increases in blood NAD+ levels, improved physical performance, improved sleep quality (deep sleep and REM), and reduced subjective fatigue. The age of participants — specifically 65+ — makes this directly applicable.

Kimura et al. (Frontiers in Aging, 2022): Adults aged 65+ received 250mg NMN daily for 12 weeks. Results: significant improvements in walking speed, physical performance, and grip strength. For women over 60 concerned about maintaining physical independence, this is the most relevant data point.

What Benefits Are Most Likely at This Life Stage

Based on the clinical trial data and the specific cellular profile of women over 60:

• Physical energy and stamina: The Igarashi trial found reduced fatigue and improved daily physical capacity at the 65+ age group. Likely the most noticeable first benefit.
• Sleep quality: The same trial found improved deep sleep and REM ratios — relevant for the fragmented sleep that characterises this life stage.
• Insulin sensitivity and metabolic function: The Yoshino trial is directly applicable. For women managing blood glucose, this is the most clinically significant data point.
• Physical performance: Walking speed, grip strength, and physical capacity improvements were documented in adults aged 65+ at 250mg daily.
• Cognitive support: Pterostilbene — in the Longevity Complex — crosses the blood-brain barrier and supports SIRT1 activation in neuronal tissue. For cognitive vitality, this is the most targeted ingredient.

Safety Considerations for Women Over 60

Women over 60 are more likely to be on regular medication — and this changes the supplement evaluation picture:

Blood pressure medication: NMN may modestly reduce blood pressure. If you are already on antihypertensives, discuss with your GP — combined effects could be additive. This is a monitoring conversation, not a contraindication.

Blood thinners: Resveratrol in the Longevity Complex has mild antiplatelet properties. If you are on warfarin, clopidogrel, or similar, discuss with your prescriber before adding Resveratrol to your routine.

Statins: No known interaction with NMN. Pterostilbene may provide complementary LDL-lowering benefit — discuss as part of your overall supplement review.

Osteoporosis medications: No known interactions. Quercetin has some evidence for bone health support through anti-inflammatory mechanisms.

Consult your GP before starting any new supplement if you manage chronic conditions or take prescription medications. The Healthdirect Australia medication interaction checker is a useful starting tool.

Dose and Protocol for Women Over 60

The most relevant clinical trials in this age group used 250mg NMN daily — and found significant benefits at that dose. Starting at 250mg (one capsule of Nadovia Pure NMN, or a half-serve of the Longevity Complex) and evaluating response over 8–12 weeks before considering 500mg is a conservative, evidence-aligned approach.

For women over 60 who want the complete protocol — addressing NAD+ restoration, sirtuin activation, senescent cell clearance, and methylation protection in one dose — the Longevity Complex at one full serving (500mg NMN) provides the most comprehensive cellular support. At this dose, TMG (included at 600mg) is particularly important for methylation protection.

FAQ

References: Yoshino M et al., Cell Metabolism (2021); Igarashi M et al., NPJ Aging (2022); Kimura S et al., Frontiers in Aging (2022); healthdirect.gov.au. Not medical advice — consult your GP regarding medications and supplements.